About
No bio available.
Skills & Expertise
No skills added yet.
Research Interests
No research interests added yet.
Connect With Me
Publications (1)
Ipilimumab 3 mg/kg was the first agent to improve survival of pretreated advanced melanoma patients. Nonconventional response patterns to ipilimumab have been reported widely, but most of these data w...
dd